- Home
- TAK vs VALE Comparison
TAK vs VALE Comparison
Compare TAK & VALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- VALE
- Stock Information
- Founded
- TAK 1781
- VALE 1942
- Country
- TAK Japan
- VALE Brazil
- Employees
- TAK N/A
- VALE N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- VALE Metal Mining
- Sector
- TAK Health Care
- VALE Basic Materials
- Exchange
- TAK Nasdaq
- VALE Nasdaq
- Market Cap
- TAK 42.5B
- VALE 40.0B
- IPO Year
- TAK N/A
- VALE N/A
- Fundamental
- Price
- TAK $13.32
- VALE $8.89
- Analyst Decision
- TAK
- VALE Hold
- Analyst Count
- TAK 0
- VALE 9
- Target Price
- TAK N/A
- VALE $14.84
- AVG Volume (30 Days)
- TAK 1.8M
- VALE 28.6M
- Earning Date
- TAK 01-30-2025
- VALE 10-24-2024
- Dividend Yield
- TAK 4.74%
- VALE 4.77%
- EPS Growth
- TAK 49.73
- VALE 4.87
- EPS
- TAK 1.27
- VALE 2.07
- Revenue
- TAK $31,732,209,416.00
- VALE $38,769,742,254.00
- Revenue This Year
- TAK $4.41
- VALE N/A
- Revenue Next Year
- TAK $1.09
- VALE $1.25
- P/E Ratio
- TAK $20.89
- VALE $4.43
- Revenue Growth
- TAK 9.43
- VALE 2.33
- 52 Week Low
- TAK $12.58
- VALE $9.00
- 52 Week High
- TAK $15.08
- VALE $16.08
- Technical
- Relative Strength Index (RSI)
- TAK 40.07
- VALE 30.87
- Support Level
- TAK $13.26
- VALE $9.33
- Resistance Level
- TAK $13.42
- VALE $9.97
- Average True Range (ATR)
- TAK 0.14
- VALE 0.20
- MACD
- TAK -0.02
- VALE -0.04
- Stochastic Oscillator
- TAK 7.95
- VALE 0.50
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About VALE VALE S.A.
Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, nickel, and copper. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in energy transition metals, its base metals business, likely the first step in separating base metals and iron ore.